BioPharm America 2012
In collaboration with EBD Group, MassBio will be bringing one of North America’s largest and most productive partnering and deal-making events back to Boston this fall.
BioPharm America™ – which last year attracted nearly 600 participating companies – will be held Sept. 19-21 at the Westin Boston Waterfront.
The event provides attendees with the opportunity to meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Organized by the EBD Group and hosted by MassBio for the third consecutive year, BioPharm America continues its growth as the unrivaled business exchange in North America for the global life science industry, specifically designed to help companies raise capital, form in- or out-licensing agreements and enter co-development deals. It is a primary event to showcase therapeutic and research innovation, including major clinical advancements.
Equipped with partneringONE®, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIOEurope® and BIO-Europe Spring®.